Dolby Laboratories Q3 EPS $0.55, Inline, Sales $298.37M Miss $301.65M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dolby Laboratories reported Q3 earnings of $0.55 per share, in line with analyst consensus. However, the company's quarterly sales of $298.37 million missed the analyst consensus estimate of $301.65 million by 1.09 percent. This represents a 19.12 percent decrease in earnings and a 3.03 percent increase in sales compared to the same period last year.
August 04, 2023 | 2:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dolby Laboratories' Q3 earnings met expectations but sales missed estimates. This could potentially impact the company's stock negatively in the short term.
Dolby Laboratories' earnings were in line with expectations, which is generally positive for the stock. However, the company's sales missed estimates, which is typically seen as a negative by the market. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100